KIT-Spin-off for cancer research was awarded

The amcure GmbH received the second prize of the CyberOne Award as well as the Special Award of the Federal State of Baden-Württemberg for its development of an active agent for the treatment of pancreatic cancer. amcure is a start-up company that was established by three scientists from the KIT Institute of Toxicology and Genetics (ITG) and a member of the KIT's innovation management. The CyberOne Award and the Federal State Special Award each are endowed with 5,000 Euro.

back